Related Experiment Videos
Anti-cancer drug discovery and development summit
1AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK. david.blakey@astrazeneca.com
Expert Opinion on Investigational Drugs
|August 29, 2003
Summary
The 5th Annual Anti-Cancer Drug Discovery and Development Summit highlighted novel targeted therapies and cytotoxic agents for oncology. With numerous anticancer drugs in development, significant therapeutic advances in cancer treatment are anticipated.
Area of Science:
- Oncology
- Pharmacology
- Cancer Therapeutics
Background:
- The 5th Annual Anti-Cancer Drug Discovery and Development Summit convened global experts in oncology.
- Discussions focused on recent therapeutic advancements in cancer treatment.
- The summit addressed both novel targeted approaches and traditional cytotoxic agents.
Framework:
- Novel targeted therapies, focusing on agents against overexpressed or overactive tumor cell targets.
- Continued role and new developments in cytotoxic agents for cancer treatment.
Implementation:
- Over 400 anticancer drugs are currently in clinical development.
- Several new anticancer drugs have recently received regulatory approval.
Implications:
- Significant therapeutic advances in cancer treatment are expected.
- Optimism for improved patient outcomes in oncology is high.